Fatal and widespread skeletal myopathy confirmed morphologically years after initiation of simvastatin therapy

被引:10
作者
Boltan, David Demitry
Lachar, Whitney
Khetan, Anita
Bouffard, John-Paul
Roberts, William Clifford [1 ]
机构
[1] Baylor Univ, Med Ctr, Dept Internal Med, Dallas, TX 75205 USA
[2] Baylor Univ, Med Ctr, Dept Pathol, Dallas, TX 75205 USA
[3] Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, Dallas, TX 75205 USA
关键词
D O I
10.1016/j.amjcard.2006.11.071
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A patient is described in whom fatal myopathy occurred, and its cause appears to be the consequence of simvastatin therapy. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1171 / 1176
页数:6
相关论文
共 17 条
[1]   Comparison of the frequency of adverse events in patients treated with Atorvastatin or Simvastatin [J].
Abourjaily, HM ;
Alsheikh-Ali, AA ;
Karas, RH .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (08) :999-1002
[2]   Clinical perspectives of statin-induced rhabdomyolysis [J].
Antons, KA ;
Williams, CD ;
Baker, SK ;
Phillips, PS .
AMERICAN JOURNAL OF MEDICINE, 2006, 119 (05) :400-409
[3]   Cytoskeletal myotoxicity from simvastatin and colchicine [J].
Baker, SK ;
Goodwin, S ;
Sur, M ;
Tarnopolsky, MA .
MUSCLE & NERVE, 2004, 30 (06) :799-802
[4]   Risk for myopathy with statin therapy in high-risk patients [J].
Ballantyne, CM ;
Corsini, A ;
Davidson, MH ;
Holdaas, H ;
Jacobson, TA ;
Leitersdorf, E ;
März, W ;
Reckless, JPD ;
Stein, EA .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (05) :553-564
[5]   Statin and fibrate associated myopathy - Study of eight patients [J].
Carvalho, AAS ;
Lima, UWP ;
Valiente, RA .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2004, 62 (2A) :257-261
[6]   Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy [J].
Chang, JT ;
Staffa, JA ;
Parks, M ;
Green, L .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (07) :417-426
[7]  
Federman DG, 2001, SOUTH MED J, V94, P1023
[8]   Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs [J].
Graham, DJ ;
Staffa, JA ;
Shatin, D ;
Andrade, SE ;
Schech, SD ;
La Grenade, L ;
Gurwitz, JH ;
Chan, KA ;
Goodman, MJ ;
Platt, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21) :2585-2590
[9]   The issue of statin safety - Where do we stand? [J].
Grundy, SM .
CIRCULATION, 2005, 111 (23) :3016-3019
[10]   Reporting rate of Rhabdomyolysis with fenofibrate plus statin versus gemfibrozil plus any statin [J].
Jones, PH ;
Davidson, MH .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (01) :120-122